Drugs / control live attenuated varicella vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02965404 Comparator | Apr → May 2016 | chickenpox | Sinovac (Dalian) Vaccine Technology Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | control live attenuated varicella vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02965404 ↗ |
| Modality | Vaccine | “control live attenuated varicella vaccine” NCT02965404 ↗ |
| Route | Intramuscular | “Single intramuscular injection of the control vaccine (0.5 ml) on Day 0” NCT02965404 ↗ |